In April of 2017, PreferUS and Sungin, a member company of the Fosun Group, announced the formation of a joint venture company.
Within this joint venture company, PreferUS and Sungin have agreed to work together in utilizing each other’s strengths to create an offering of hospital management, consulting and investment services. These services include; 1) comprehensive assessment programs, 2) healthcare facilities planning, 3) hospital performance improvement, 4) advanced clinical service line development, 5) hospital management services and 6) medical tourism program services.
Fosun is involved in two major business sectors; integrated finance (wealth) and industrial operations. These two areas have accumulated total assets exceeding RMB430 billion. Fosun has expanded its landscape with over 120 on-going projects in over 40 cities around the world.
In 2014, Fosun International was named as one of the "Most Admired Companies in China" by Fortune Magazine. Fosun International also ranked in the top five companies on the "Diversified" industry ranking. Additionally, in May of 2016, the company was ranked 434th on the Forbes Global 2000 list, (an increase of over 100 places from 2015), while ranking 47th amongst all Chinese enterprises. This also marked the first time that Fosun has ranked among the top 500 global companies.
PreferUS brings an impressive group of four major U.S. institutional healthcare partners and over 100 U.S. individual physician investors comprised of orthopedic surgeons and cardiovascular specialists. Since PreferUS’ entry to China in 2009, we have established our western healthcare brand and have acquired five major China partners to successfully implement their healthcare consulting and management services.
PreferUS views the complimentary set of expertise and resources from both entities as a major advantage for future growth and the establishment of a world class hospital consulting, management and investment services company.